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PROLONGED ALTERATIONS OF CARDIOMYOCYTE GENE EXPRESSION 
FOLLOWING LOW DOSE HIGH CHARGE AND ENERGY PARTICLE 
RADIATION—IMPLICATIONS FOR FUTURE DEEP SPACE TRAVEL 
JOHN H. SCHWAB V. 
ABSTRACT 
Introduction: Space exploration is ultra-hazardous and unpredictably dangerous. One 
area of significant concern is the exposure of astronauts to deep space radiation and the 
development of deleterious health effects. Earth's magnetic field and atmosphere both act 
to deflect the majority of deep space radiation, protecting humans on the surface of earth 
as well as astronauts in low Earth orbit missions. Because this type of radiation is not 
encountered terrestrially, very limited evidence exists in regards to the effects on the 
well-being. Deep space radiation, which consists of high charge and energy (HZE) 
particles, may be experimentally reproduced for studies using a particle accelerator. The 
long-term degenerative effects of cosmic irradiation on the cardiovascular system are 
vastly unknown. Detailing the molecular response within cardiomyocytes after exposure 
to HZE irradiation will provide needed knowledge for scientists to accurately assess the 
cardiovascular risks associated with deep space radiation exposure. 
Objective: The primary objective of this study is to characterize the molecular alterations 
of gene expression within murine cardiomyocytes following exposure to two different 
types of HZE. 
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Methods: Wild type C57B1/6NT (Taconic) mice were exposed to either 90 cGy, 1 GeV 
proton (1H) or 15 cGy, 1 GeV/nucleon iron (56Fe) HZE particle-radiation. Radiation 
exposure was performed at the NASA Space Radiation Laboratory located at the 
Brookhaven National Laboratory (Upton, NY). Biological samples were taken and 
transcriptome profiling was performed at various time points following irradiation (1, 3, 
7, 14, and 28 days). 
Results: Samples exposed to 56Fe-IR displayed significant levels of gene modulation, 
while proton-irradiation failed to elicit significant alterations in cardiomyocyte gene 
transcription compared to sham-irradiated samples. Network pathway analysis of iron-
irradiated samples identified multiple biological pathways being significantly modulated. 
These biological pathways included cell death and survival, free radical scavenging, and 
inflammatory processes. Multiple points of upstream transcription regulation were 
identified as key nodes for regulating downstream expression. Validation of the signal 
transduction network by protein analysis showed that particle-IR clearly regulates a long 
lived signaling mechanism for p38 MAPK signaling and NFATc4 activation. 
Electrophoresis mobility shift assays supported the role of transcription factors GATA-4, 
STAT-3 and NF-B as key regulators.  
Conclusions: The molecular response to 56Fe-IR is unique and induces long-term 
modulations of gene expression in cardiomyocytes that last up to at least 28 days 
following radiation exposure. However, exposure to 1H-IR failed to elicit significantly 
robust alterations in gene expression in cardiomyocytes. Additionally, proteins involved 
 vii 
 
in signal transduction and transcriptional activation via DNA binding play a significant 
role in the molecular response following HZE particle radiation. This study may have 
multiple implications for NASA’s efforts to develop cardio-degenerative risk estimates 
for astronauts participating in future deep space missions. By identifying molecular 
mechanisms and potential molecular markers, scientists can begin to assess excess 
relative risks and develop strategies to mitigate risks of developing physiological changes 
which may compromise future missions. This study may also have major safety 
implications for the increasing number of patients receiving conventional and particle 
radiotherapy. 
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INTRODUCTION 
 
Space exploration is ultra-hazardous and unpredictably dangerous. However, not 
only has space exploration acted to advance our knowledge of what lies beyond the world 
that we are familiar with, but it has also generated many advances in science and 
technology that have benefited terrestrial life. As space exploration continues to push the 
bounds of what we know and enter uncharted territories, a constant assessment and 
estimation of risk placed onto astronauts is an essential first step. Dangers faced by 
astronauts are sometimes obvious, even to the general public, such as a catastrophic 
failure of the mission vehicle. Other hazards however may be less identifiable not only to 
the general public, but astronauts and scientists alike. Even successful missions where 
astronauts complete their objectives and return safety, deleterious effects toward 
astronaut's health may still have occurred. The effects to their health may be permanent, 
long lasting and/or lay dormant until later in life. Since the origins of the space program 
the astronauts’ exposure to radiation has been a major concern. 
 
Basics of Radiation Biology 
Radiation can be generalized as either ionizing or non-ionizing radiation by its 
ability to cause ionization of atoms it encounters. Ionizing radiation (IR) may further be 
categorized as directly ionizing (IR consisting of charged particles) or indirectly ionizing 
(IR consisting of neutral particles). By nature, both direct and indirect IR causes the loss 
of an electron with the molecules they interact with. Because of their charged properties 
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direct IR tends to interact with more target atoms than does indirect IR due to the 
electromagnetic forces experienced by charged particles. Linear energy transfer (LET) 
describes how much energy IR particles transfer to the material traversed per unit 
distance and varies on both the IR and the specific composition of the material traversed. 
Many studies have attempted to relate linear energy transfer to the relative biological 
effectiveness (RBE) of radiation, with inconsistent results1. The relationship varies 
widely depending on the nature of the biological material, and the choice of endpoint to 
define effectiveness. Even when these variables are held constant, different radiation 
spectra with similar LET may have significantly different RBE1. 
Further complicating the relationship between LET and RBE are the effects of 
delta rays. Secondary electrons may be produced if primary charged particles created by 
IR carry enough energy that they themselves can cause downstream ionization. This type 
of lateral propagation of ionization is called delta radiation. As in the case of high charge 
and energy (HZE) particle-IR, different types of radiation can produce significantly 
different degrees of delta radiation and therefore may significantly underestimate LET 
approximations2. Different energies of the same type of radiation can also cause differing 
degrees of delta radiation. Increasing the degree of delta radiation also increases the 
overall dose of radiation astronauts are exposed to. Figure 1 demonstrates the complex 
relationships between primary particles, radiation energy, the spacecraft structure, and the 
generation of secondary particles. It is an interesting observation that while increasing the 
thickness of aluminum shielding is effective in protecting astronauts from large doses of 
proton-IR (typical of solar particle events), it can have the opposite effect for HZE-IR3. In 
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this study increasing the thickness of shielding was observed to increase the overall dose 
of HZE-IR through increased production of delta radiation3. A complete understanding of 
all these aspects is critical for designing radiation shielding to mitigate radiation exposure 
health risks. The exact shielding used may also need to be mission specific to protect 
against which radiation type(s) are anticipated for a given mission.  
 
Figure 1: The Transport of Primary Radiation Through the Spacecraft Structure and Contents and 
the Generation of Secondaries. The generation of secondaries are critically dependent on many factors 
including the energy of radiation, primary radiation type, and the structures that propagate secondaries. 
(Figure taken from Benton et al., 2001)3. 
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Observed differences in the RBE following IR can also be attributed to both 
differences in radiation quality and specific properties of the biological sample studied. 
Variations in RBE due to differences in radiation quality can depend on factors including: 
exact type of radiation, radiation composition of multiple types, radiation energy, dose, 
dose rate, fractionation, LET, and the effects of delta rays. Discrepancies in observed 
RBE may also depend on the biological sample and sources of variations may include: 
the specific biological effect analyzed, species studied, specific organ targeted, bystander 
effects, age of specimen, stress/oxidation state of host, and the presence of other 
underlying pathologies before radiation exposure.  
 
Extrapolation of Terrestrial Radiation—Historical Perspective  
It has previously been thought that the heart is relatively radiation resistant and 
that damage to the heart could only be induced by higher doses of linear energy transfer 
radiation (doses > 10 Gy), which have been observed after the course of radiation therapy 
for the treatment of certain cancers4,5. At relatively high doses (5-50 Gy) a clear link has 
been established between IR and the development of long-term cardiovascular disease 
and cardio-degenerative processes4,5. Following non-HZE radiotherapy there is a dose-
dependent increase in the incident and development of a variety of cardiovascular 
diseases6-9. However, growing epidemiological evidence suggests there is increased risk 
of mortality from myocardial infarction and other forms of ischemic heart disease even at 
relatively low doses (0.5-1.0 Gy) of LET radiation10-12. These observations have caused a 
necessary reassessment of the CV risks associated with low dose IR. In addition to 
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growing uncertainty of the health hazards associated with low dose IR, astronauts on 
deep space missions will be exposed to a different type of radiation containing HZE 
particles. This type of radiation is not naturally encountered terrestrially, and only 
recently has there been a need to assess the biological effects of HZE particle-irradiation. 
With the increasing use of particle type radiotherapy and the need to assess the health 
risks associated with astronaut exposure to HZE particle-IR, further detailed studies are 
warranted. 
 
Galactic Cosmic Radiation 
Some of the biggest health hazards of space exploration are those associated with 
radiation exposure. Particularly concerning is the hazard from radiation that could be 
encountered on future deep space missions. Radiation encountered in deep space is 
significantly different than that encountered terrestrially or during low Earth orbit (LEO) 
missions. During LEO missions, such as a mission to the international space station, 
radiation exposure following solar particle events (SPE) has been the greatest radiation 
concern. These SPEs are solar disturbances that cause a large flux of energetic particles, 
in which 90% of the IR dose equivalent is due to proton radiation13. 
Galactic cosmic rays (GCR) make up the background radiation that permeates 
interplanetary space. Contained among this deep space radiation are HZE particles such 
as protons, alpha particles, and heavy nuclei such as silicon, helium, and iron. Deep space 
radiation is very dynamic and contains particles that span a wide range of energy, some 
particles approaching 107 MeV/nucleon13. While the number of HZE particles 
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encountered is relatively small, their high charge and high energy properties cause them 
to be densely ionizing. Although only 1% of the composition of GCR is from ions 
heavier than He, the IR dose equivalent for this 1% is estimated to be >40%13. Earth's 
magnetic field acts to deflect charged particles, thus helping to protect astronauts on LEO 
missions. Humans on the surface of Earth are additionally protected from GCR by the 
atmosphere, which mitigates the vast majority of any GCR that may have penetrated the 
magnetosphere13. 
While the original Apollo missions took astronauts beyond the protection of 
Earth’s geomagnetic field, significant radiation exposure did not occur because of the 
relatively short mission duration3. As NASA considers and plans long duration missions 
to the moon and mars, radiation exposure remains to be a technological limiting factor. 
Astronauts will be exposed to considerable HZE radiation during potential missions to 
Mars. The duration of a potential mission to Mars has been estimated to be 940 days; 540 
days will be spent on the Martian surface and 400 days will be spent during transit14. 
During a mission of this length astronauts may potentially be exposed to more than 500 
mGy from GCR alone15. For comparison, the greatest radiation exposure (radiation from 
all types) during the Apollo missions was estimated to be 11.4 mGy during the Apollo 14 
mission3. For a 940-day mission it has been hypothesized that radiation exposure 
associated long-term mortality risks may be 2-3 times greater than NASA's radiation 
standard lifetime aggregate limit of 3%14. 
The major health concerns and effects that are predicted following exposure to 
deep space radiation are depicted in Figure 2. While it was previously predicted that the 
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greatest health hazard of low dose deep space radiation exposure was the risk of 
developing cancer, it has recently been suggested that there may also be significant risk 
in developing cardiovascular (CV) disease16. The average age of astronauts is 46 and 
therefore astronauts are naturally at risk for developing CV disease; exposure to deep 
space radiation may greatly increase this risk and increase the probability of adverse CV 
events occurring inflight14.  
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Figure 2: Select Health Effects Due to Space Radiation Exposures. (Figure taken from Chancellor et al., 
2014)17. 
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Molecular Mechanics of HZE Particle Irradiation  
Currently little evidence is available detailing the specific effects that HZE 
particle radiation has on biological tissue, especially in vivo. This is due to a lack of 
natural interaction between humans or animals inhabiting Earth and HZE particle-IR18. 
Furthermore experimental production of HZE particle radiation—like that contained with 
GCR—is an extremely expensive endeavor, which its generation is only possible through 
the use of a particle accelerator. Animal models are critically important to gain an 
understanding of the biological effects of HZE particle-irradiation. These in vivo studies 
are essential for our ability to reduce the uncertainties in estimating the health risks 
associated with HZE particle exposure and may further aid in the development of risk 
mitigation methods. 
HZE particle-IR has significant biological effects, causing both specific and non-
specific oxidative injury19. Potential interactions, cellular targets, and the effects of HZE-
irradiation are demonstrated in Figure 3. Oxidative injury due to HZE-IR can cause a 
variety of deleterious effects to specific tissues and organ systems, ranging from: 
hematopoietic toxicity; to increased accumulation of Aβ plaques; to radiation 
carcinogenesis from mitochondrial damage19-22. The bystander also known as the 
abscopal effect further complicates how certain biological tissues respond to IR. Even at 
low doses, LET-IR has been observed to induce long lasting effects on distant organs that 
were not directly irradiated23. 
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Figure 3: Effects of High Charge and Energy (HZE) Irradiation in Mammalian Cells. (A) HZE 
particles that traverse a cell may be densely ionizing. The ionization of cellular macromolecules may either 
be direct or indirect. Absorption of HZE-IR can cause the generation of both reactive oxygen species 
(ROS) and reactive nitrogen species (RNS) in addition to multiple downstream effects. (B) DNA damage 
induced by HZE-IR is highly dependent on the properties and specific quality of radiation. In particular 
higher LET particle radiation causes more interactions and subsequent damage. (Figure taken from Li et al., 
2014)19. 
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Current Evidence of HZE Particle Irradiation   
Few studies have analyzed the specific biological effects of low dose HZE 
particle-IR, especially the organ-specific and non-cancerous effects. Among these few 
studies, significant molecular alterations were observed in skeletal muscle fibers 
following low dose HZE particle-IR24. Specifically they reported that low dose HZE 
particle-IR caused significant alterations in [Ca2+]i homeostasis, reduced depolarization 
evoked Ca2+ from the sarcoplasmic reticulum, and increased numbers of centrally located 
nuclei in skeletal muscle fibers24. This evidence may suggest the molecular begins of an 
IR-induced myopathy. Furthermore this evidence may also suggest that the heart could 
show similar susceptibility following HZE particle-IR. 
One recent study, the first publication known to date, detailed the biological and 
physiological effects of HZE particle-IR on the cardiovascular system25. This article 
analyzed the effects HZE particle-IR (56Fe; 0.15 Gy, 1GeV/nucleon, and 1H; 0.5 Gy, 
1GeV) has on cardiac function and physiology up to 10 months following IR. In addition 
to analyzing the effects of IR and aging alone, they also studied how preconditioning 
with particle-IR altered cardiac function and the heart’s ability to heal after induction of 
an acute myocardial infarction25.  
In their IR plus aging model alone they found that HZE particle-IR caused 
significant alterations of physiologic parameters assessed in vivo by echocardiography 
and hemodynamic measurements of the left ventricle25. In their acute myocardial 
infarction (AMI) plus aging model that proceeded radiation preconditioning treatment, 
they found significant physiological alterations in the cardiac function, healing processes, 
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and infarction size25. These differences were encountered not only between particle-IR 
and the sham-IR controls, but also between 56Fe-IR and 1H-IR treatment groups and also 
varied as a function of time25. Data showed that recovery from an AMI was hindered 
after 56Fe-IR preconditioning, while—surprisingly— 1H-IR preconditioning appeared to 
be beneficial in certain instances25. What remains less certain are the molecular 
mechanisms that precipitated these divergent findings and whether there are specific 
molecular mechanisms that are responsible for the deleterious or beneficial physiologic 
manifestations.  
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Specific Aims/Objectives 
Currently there is minimal data on the non-cancerous effects of HZE particle-IR 
and the cardiovascular system (CV). Investigators have analyzed the risks of radiation on 
cardiovascular disease, but these studies have focused on the effects following non-HZE 
particle-IR and do not exemplify the type of radiation present in GCR. The long-term 
degenerative effects and changes that HZE particle-IR inflicts on the CV system are 
unknown, thus hindering the ability to accurately assess the health risks of GCR exposure 
of future interplanetary missions. These risks need to be accurately assessed before any 
deep space mission can be conducted. Once the risks are accurately assessed defensive 
mechanisms and strategies will need to be elucidated to mitigate any excess risk 
associated with HZE particle exposure.  
For this reason model systems are necessary. A murine mouse model will be 
utilized to estimate the risk this type of HZE particle-IR will pose to future astronauts on 
deep space missions. The first goal of this study will be to identify specific time-
dependent alterations of gene expression following HZE-IR. Using pathway analysis, 
cellular functions and process will be identified. Genes identified as being significantly 
altered will be analyzed and used to deduce any commonalities among upstream points of 
regulation. Previous work has identified divergent physiologic effects between low dose 
1H-IR and 56Fe-IR. This study will assess for similarities and differences in long-term 
alterations of gene expression between low dose 1H-IR and 56Fe-IR. While the projects 
mainly concern risks to astronauts traveling beyond the protection of earth's atmosphere 
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and magnetic field, results could be beneficial for assessing CV risks in patients receiving 
cancer treatment with particle type radiotherapy. 
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METHODS 
 
Experimental Animal Model and Radiation Dosimetry 
 Total body irradiation of wild type C57B1/6NT (Taconic) male mice was 
performed at the NASA Space Radiation Laboratory located at the Brookhaven National 
Laboratory (Upton, NY). At the time of irradiation, mice were aged 8-9 months. All mice 
were handled and housed in accordance with the policies and procedures set forth by the 
GeneSys Research Institute Inc., Institutional Animal Care and Use Committee (Boston, 
MA). The experimental group received either a dose of 0.15 Gy iron radiation with 1 
GeV/nucleon 56Fe ions (LET ~151 keV per µm) or 0.9 Gy proton radiation with 1 GeV 
1H ions (LET ~0.22 keV per µm). Radiation dose rates were 0.05 Gy/min for iron and 
0.17 Gy/min for proton. Experimentally irradiated mice were harvested at 1, 3, 7, 14, and 
28-days post-irradiation and results were compared to a sham-irradiated control group. 
There were a total of 29 mice in this experiment, 15 in the iron irradiated group and 14 in 
the proton irradiated group. Among the iron irradiated group three mice were harvested at 
days 1 and 3, while two mice were harvested at days 7, 14, and 28. Among the proton 
irradiated group three mice were harvested at day 3, while two mice were harvested at 
days 1, 7, 14, and 28. Each experimental irradiated group also included three sham-
irradiated mice serving as controls.  
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Cardiomyocyte Isolation  
Left ventricular cardiomyocytes were isolated using a standard protocol 
previously described, which includes rapid excision of the heart, cannulation of the aorta, 
collagenase digestion, and Ca2+ gradient selection26-29. Over 90% Ca2+ tolerant CMs were 
obtained, but these may contain small numbers of endothelial and/or inflammatory cells. 
Following CM isolation, RNA was extracted via TRIzol (Life Technologies, Grand 
Island, NY) according to the manufactures protocol. The quantity and quality of RNA 
isolated was assessed using the 2100 Bioanalyzer (Agilent., Santa Clara, CA).  
 
Gene Expression Microarrays and Data Analysis  
Expression arrays were selected to compare overall expression differences and 
expression differences across similar time points between non-irradiated control samples 
and irradiated samples (iron or proton irradiated samples vs. sham irradiated controls). 
Microarrays were also selected to provide the temporal variations of gene expression 
within each of the two irradiation groups. The Affymetrix GeneChip 1.0ST array system 
(Affymetrix, Inc., Santa Clara, CA) at the Boston University School of Medicine 
Microarray Core Facility (Boston, MA) was used for genome-wide expression profiling.  
To analyze the effects of iron irradiation a total of 15 microarrays were performed 
on individual mice; three mice per group (3 replicate arrays) for the non-irradiated 
controls, and days 1 and 3 post irradiation, and two per group (2 replicate arrays) at days 
7, 14, and 28 post irradiation. To analyze the effects of proton irradiation a total of 14 
microarrays were performed on individual mice; three mice per group (3 replicate arrays) 
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for the non-irradiated controls and day 3 post irradiation, and two mice per group (2 
replicate arrays) at days 1, 7, 14, and post irradiation.  
To determine the effects of each type of radiation compared to the non-irradiated 
controls, data were log2 transformed, normalized, and corrected for background noise. 
One-way ANOVA was performed for statistical analysis and a cut-off p-value <0.05 was 
used. Results were adjusted with the Benjamini-Hochberg correction method for a False 
Discovery Rate (FDR) < 10%30. All samples having an average signal above background 
noise were then filtered using a minimum cut-off value of 20 and must have had at least 
one sample group with a >1.5-fold absolute difference compared to the non-irradiated 
control group. While this filtering resulted in 400 unique genes for the iron dataset, no 
genes were identified for the proton dataset using the FDR cutoff <10%. To increase the 
sensitivity in the detection of alterations of gene expression within the proton dataset, the 
FDR threshold was subsequently raised to <33% and 133 genes were identified. After 
filtering genes for an average expression signal >20 in addition to an absolute change 
>1.5 fold in expression reduced the list to 21 genes.  
In order to analyze distinctions between iron and proton irradiation, data were 
data were log2 transformed, normalized, and corrected for background noise. Data were 
then filtered for an absolute change > 1.5 fold using an FDR threshold <5%. Genes 
identified using these criteria were used for pathway analysis as described below. 
Microarray data was then uploaded to the Gene Expression Omnibus repository 
(http://www.ncbi.nlm.nih.gov/geo/), the accession number will be made available after 
publication. 
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Biological Pathway Analysis  
Genes identified as having significantly altered levels of expression underwent 
functional analysis and upstream regulation was predicted using the Ingenuity Pathway 
Analysis (IPA) core analysis software (Ingenuity® Systems, http:// ingenuity.com) as 
previously described31. Only limited functional pathway analysis was performed on the 
proton because very few genes met both statistical and filtering criteria. The 400 genes 
meeting these criteria from the iron dataset were uploaded and resulted in 381 annotated 
genes. Core analysis was performed for each time point, days 1, 3, 7, 14, and 28, and 
resulted in 164, 215, 193, 83, and 162 gene lists, respectively. Gene lists generated from 
the microarray experiments were entered into the TFactS software program 
(http://www.tfacts.org/) to predict which transcription factors were significant to 
downstream gene expression, as previously described32. Predicted transcription factors 
and potential genes regulated were identified as significant using a cutoff p<0.05. 
Functional categories or individual upstream regulators with a p<0.05 and a z-score 
below -2.0 (inhibited) or above +2.0 (activated) were considered significant using the 
IPA core analysis software. 
 
Western Blot Analysis   
A 3x3 mm section of the left ventricle was collected from sham-irradiated control 
mice and iron-irradiated mice on days 7, 14, and 28. Whole tissue lysates were prepared 
using RIPA lysis buffer (Fisher Scientific, Pittsburg, PA). Bradford assay was used to 
quantify total protein in order to calculate the volume needed to load 50 µg of total 
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protein from each sample. Lysates were assayed by immunoblotting after SDS-PAGE to 
quantify both total (T) and phosphorylated (p) protein levels of both NFATc4 and p38 
MAPK. To accomplish this phosphorylated and non-phosphorylated specific primary 
antibodies for NFATc4 (Ser168/170, Santa Cruz Biotechnology, Santa Cruz, CA) and 
p38 (Thr180/Tyr182, Cell Signaling, Danvers, MA) were used, followed by conjugated 
horseradish peroxidase (HRP)-linked goat anti-rabbit secondary antibodies (Cell 
Signaling). Glyceraldehyde 3-Phosphate Dehydrogenase (GADPH) and α-Actinin 
expression were used to normalize protein loading. Proteins were visualized using the 
enhanced chemiluminescence western blotting method (ECL, Fischer Science). 
Brightness of western blot bands were analyzed with densitometry analysis to obtain total 
and phosphorylated levels of a protein. Image J software was then used to measure each 
band intensity along with the corresponding loading control. 
 
Electrophoretic Mobility Shift Assay  
An electrophoretic mobility shift assay (EMSA) was performed following a 
previously described method33,34. Nuclear extracts were prepared from the left ventricle 
of iron irradiated and sham irradiated mice. Small tissue pieces were homogenized in 
lysis buffer containing 10 mM HEPES, pH 8.0, 10 mM KCl, 2 mM MgCl2, 1 mM 
dithiothrietol (DTT), 0.1 mM EDTA, 0.1 mM EDTA, 0.1 mM 
phenylmethylsulfonylfluoride (PMSF), 10 µl of protease inhibitor (Sigma-Aldrich), and 
0.2% Nonidet P-40.  Total protein concentration from each sample was measured using 
the bicinchoninic acid (BCA) method following the manufacturer’s protocol (Pierce, 
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Rockford, IL). An EMSA was performed using double-stranded oligonucleotides of NF-
κB, STAT-3, and GATA-4 (NF-κB: 5’-AGT TGA GGG GAC TTT CCC ACG C-3’; 
STAT-3: 5’-GAT CCT TCT GGG AAT TCC TAG ATC-3’ and GATA-4: 5’-CAC TTG 
ATA ACA GAA AGT GAT AAC TCT-3’) end-labeled with T4 polynucleotide kinase. 
For competition assay 20 µg nuclear extracts were pre-incubated on ice for 5 min with 
homologous unlabeled NF-κB, STAT-3, and GATA-4 oligonucleotides, 50-100 times in 
excess of the labeled probe concentration. After addition of [γ-32p]-labeled probes of each 
respective transcription factor, all samples were electrophoresed at 100 V through 6% 
polyacrylamide gels in a Tris-glycine buffer (25 mM Tris, 190 mM glycine and 1 mM 
EDTA). Levels of transcriptional activation were detected and quantified using either 
PhosphorImager analysis (Bio-Rad, Hercules, CA) or exposure to X-ray film and semi-
quantitated using the NIH Image J integrated density program. 
 
Quantitative Real Time-PCR Analysis  
RNA was extracted from cardiomyocytes and cDNA was created from each 
sample using the TaqMan Reverse Transcription Kit (Life Technologies). Four genes 
(IGFBP6, CCR9, ADAM19, and DBP) were selected for qRT-PCR to confirm the 
findings from the gene expression microarray analysis. Samples analyzed were from the 
non-irradiated controls and iron-irradiated mice from each time point. Samples were 
analyzed using an Applied Biosystems 7300 Real Time PCR machine and its software. 
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Statistical Analysis  
Results in graphs are expressed as means ± SEM. Significant differences were 
evaluated using the Student t-test, one-way ANOVA, right-tailed Fisher’s exact test, and 
Chi-squared when appropriate. Differences were considered significant at P<0.05. 
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RESULTS 
 
Distinct Changes in Transcriptional Activity  
Left ventricle cardiomyocytes were isolated to examine the temporal response 
following total body particle radiation. Adult C57Bl/6NT mice aged 8-9 months were 
exposed to one of two types of particle radiation, 15 cGy of 1 GeV/n 56Fe ions or 90 cGy 
of 1 GeV 1H ions. Samples were collected at 1, 3, 7, 14, and 28 days following irradiation 
along with non-irradiated controls. A total of 29 microarrays were created to analyze 
global changes in gene expression. 
Compared to the control group, 5,220 genes were identified as being differentially 
expressed following iron-irradiation (p <0.05). A less robust response was observed 
following proton-irradiation. Here only 1,651 genes were identified as being 
differentially expressed compared to sham-irradiated mice (p <0.05). After applying an 
FDR < 10%, 1,538 genes were identified in the iron dataset while the proton dataset did 
not result in any genes showing significant alterations of expression. Further filtering of 
the iron dataset to display only genes with an average signal >20 and a minimum ±1.5-
fold change, resulted in 400 genes displaying significant alterations in the degree of their 
expression (Figure 4A). Qualitatively interpreting Figure 4A, there is a predominant 
decrease in gene expression on day 1 and on day 3 following iron-IR. This is followed by 
a wave like alteration of gene expression with marked increases on days 7 and 28 (Figure 
4C). 
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FIGURE 4: Gene Microarray Results for Proton and Iron Irradiations. Hierarchical clustering using 
an Euclidean algorithm for gene lists with a fold-change greater than ±1.5 from (A) iron-IR samples with 
an FDR<0.1 or (B) proton-IR samples with an FDR <0.33. Relative fold-changes compared to the non-IR 
controls are shown (C) plot of the average fold-changes by day using the 400 genes identified from the 
iron-IR.  Whiskers show the 5th to 95th percentile with outliers (solid circles).  Red dashed lines show ±1.5 
fold-change and blue dash line shows no change compared to non-IR control samples. 
 
No genes were identified from the proton dataset using the strict FDR <10%. 
Subsequently, the FDR threshold was raised to <33% to increase the sensitivity, with a 
tradeoff being a decrease in specificity. While this increased sensitivity resulted in 133 
genes, filtering for an average signal >20 and genes displaying greater than an absolute 
1.5 fold change in expression levels reduced the list to only 21 genes (Figure 4B). 
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Compared to the non-irradiated controls, iron irradiation elicited a far more 
prominent response in cardiomyocyte gene expression (400 genes, FDR <10%) than did 
proton irradiation (21 genes, FDR <33%; 0 genes, FDR <10%). Direct comparison of the 
genes identified by iron irradiation (FDR <10%) and the genes identified by proton 
irradiation (FDR <33%), only four genes were observed with altered levels of expression 
common to both types of radiation (Car14, Dbp, Lcn2, and Trim7). This possibly 
highlights a very distinct difference in the molecular mechanisms and alterations of gene 
expression between these two radiation types. 
 
Biological Pathway Analysis 
 To better understand the significance of the genes identified as showing altered 
levels of expression, IPA’s functional annotation library was used to analyze the 381 
annotated genes generated comparing iron-irradiation mice to sham-irradiated mice at the 
same time points. The data from the comparison of proton-irradiated mice and sham-
irradiated mice was not used due to the few number of genes identified as being affected. 
The remainder of this article will focus on and analyze the biological effects of iron-
irradiation, unless otherwise stated. The IPA database was utilized to generate biological 
categories and cellular functions from the genes identified as showing significantly 
altered levels of expression. This process was done for each time point. Functional 
categories identified as showing statistical significance to the data (less than a threshold 
p-value) and resulting in a z-score > 2.0 (activated) or < -2.0 (inhibited) are displayed by 
time point in Table 1.  
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Table 1: IPA Identified Functional Categories and Functions Modulated by Iron- 
Irradiation.  Functional categories and functions were analyzed by day and considered 
significant with a z-score > 2.0 (activated), or below < -2.0 (inhibited). 
TIME FUNCTIONAL CATEGORY (FUNCTION) P-VALUE 
Predicted 
Activation 
Activation  
z-score 
Day 1 
Inflammatory Response (arthritis, rheumatic 
disease & inflammation) 
2.86E-08 Decreased -2.52 
Cellular Growth and Proliferation (proliferation) 2.50E-03 Increased 2.07 
Day 3 
Cardiovascular Disease (vascular disease) 7.14E-07 Decreased -2.33 
Cellular Development (differentiation) 1.39E-07 Decreased -2.27 
Free Radical Scavenging (synthesis & production) 4.90E-05 Decreased -2.70 
Inflammatory Response (arthritis, rheumatic 
disease & inflammation) 
1.67E-06 Decreased -2.15 
Day 7 
Infectious Disease (infection) 1.75E-11 Decreased -2.72 
Cell Death and Survival (cell death, necrosis & 
apoptosis) 
5.18E-04 Increased 2.00 
Cell-To-Cell Signaling and Interaction (binding) 8.08E-05 Increased 2.74 
Free Radical Scavenging (production) 6.98E-04 Increased 2.002 
Hematological System Development and 
Function, Cellular Development & Tissue 
Morphology (differentiation & quantity) 
9.27E-06 Increased 2.07 
Inflammatory Response (arthritis, rheumatic 
disease, inflammation & immune response) 
3.20E-05 Increased 2.10 
Molecular Transport (quantity) 1.10E-03 Increased 2.28 
Day 14 
Cell Death and Survival (apoptosis) 9.04E-05 Decreased -2.21 
Cell-To-Cell Signaling and Interaction 
(activation) 
1.50E-02 Decreased -2.59 
Inflammatory Response (immune response) 3.09E-04 Decreased -2.39 
Tissue Development & Cellular Assembly and 
Organization (formation & fibrogenesis) 
1.25E-03 Decreased -2.01 
Day 28 
Inflammatory Response (activation) 2.18E-03 Decreased -2.41 
Hematological System Development and Function 
& Tissue Morphology (quantity) 
2.24E-03 Decreased -2.00 
Cell Death and Survival (apoptosis) 1.05E-02 Decreased -2.00 
Cell Death and Survival (survival) 1.76E-03 Increased 2.08 
Cardiovascular System Development and 
Function 
8.27E-05 Increased 2.13 
Embryonic, Organismal, and Organ Development, 
& Tissue Development (development) 
3.02E-03 Increased 2.32 
Free Radical Scavenging (production) 8.41E-03 Increased 2.15 
Hematological System Development and 
Function, Humoral Immune Response & Tissue 
Morphology (quantity) 
1.19E-04 Increased 2.33 
 
 26 
 
Analysis shows that iron-irradiation induced changes in gene expression that were 
significantly representative of the activation or inhibition of multiple biological functions. 
Several functional categories displayed a wave like response that is reminiscent of 
previous observations following exposure to high dose low-LET gamma-radiation35. 
After a brief activation in the genes associated with cell proliferation (day 1), there was 
considerable inhibition of cell differentiation (day 3), increased activity of cell death and 
cell necrosis (day 7), followed by an inhibition of genes associated with apoptosis (days 
14 and 28) and an activation of cell survival processes and towards one month post-
irradiation. Genes associated with the synthesis and production of free radical scavenging 
production were found to be inhibited within the first week, while activated on days 7 and 
28. In the first week, there was an inhibition of the inflammatory response among genes 
functionally associated with arthritis, rheumatic disease, and inflammation. This was in 
contrast to the increase in this category observed on day 7 after irradiation.  
From the functional categories identified three were selected (due to significance 
over all time points) for further analysis using networking diagrams to gain a visual 
appreciation of the complexity of their interactions and regulation following iron-
irradiation. These network diagrams were created for the functional categories of cell 
death and survival, free radical scavenging, and inflammation (Figures 5, 6, and 7).  
 27 
 
 
FIGURE 5: Cell Death and Survival-Related Functional Activity Network of Gene Expression. 
Network was generated using IPA for gene expression following 56Fe-IR relative to non-IR control for (A) 
day 1, (B) day 3, (C) day 7, (D) day 14, and (E) day 28 post exposure. 
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FIGURE 6: Free Radical Scavenger Functional Activity Network of Gene Expression. Network was 
generated using IPA for gene expression following 56Fe-IR relative to non-IR control for (A) day 1, (B) day 
3, (C) day 7, (D) day 14, and (E) day 28 post exposure.   
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FIGURE 7: Inflammatory-Related Functional Activity Network of Gene Expression. Network was 
generated using IPA for gene expression following 56Fe-IR relative to non-IR control for (A) day 1, (B) day 
3, (C) day 7, (D) day 14, and (E) day 28 post exposure. 
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What can be easily appreciated, visually, is the wave like response iron-irradiation 
induces on the expression of numerous genes. The first response many of these genes 
have is an early inhibition (days 1 and 3), followed by an activation of their expression 
towards day 7. At days 14 and 28 it becomes harder to generalize, but many genes 
display a second wave like round of inhibition of gene expression compared to the sham-
irradiated samples. 
To help explain the cause of the alterations in downstream gene expression, the 
400 genes identified from the iron-irradiation dataset were used to predict relationships to 
upstream regulators. Using the program located at http://www.tfacts.org, the gene list 
identified transcription factors and points of upstream regulation (p < 0.05, FDR < 10%). 
Both cytokines and transcription binding factors were indicated as playing a role in 
transcriptional regulation. Table 2 displays upstream regulators identified as playing a 
significant role in the alteration gene expression as a function of time following iron-
irradiation. 
Network diagrams were created for each day to show the relationship between the 
genes identified as being differentially expressed and their respective upstream regulator 
(Figure 8).  Large networks with a central regulator of transcription and numerous of 
downstream effected genes were especially prominent on days 1, 3, and 7 (Figure 8A-C). 
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FIGURE 8: Downstream Gene Targets of Predicted Upstream Transcriptional Regulators. Networks 
were generated using IPA for gene expression following 56Fe-IR relative to non-IR control for (A) day 1, 
(B) day 3, (C) day 7, (D) day 14, and (E) day 28 post exposure. 
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Table 2: Predicted Upstream Regulators Identified Based on the Iron-Irradiation Dataset Overlap 
with IPA Database.  Only transcriptional regulators showing a significant p-value < 0.05 and z-score more 
than +2.0 (activated) or less than -2.0 (inhibited) are displayed.  
TYPE 
UPSTREAM  
REGULATOR 
Z-SCORE (# OF TARGET GENES) 
Day 1 Day 3 Day 7 Day 14 Day 28 
Transcription Regulator MYCN +2.22 (5) - - - - 
Transcription Regulator TP53 - -2.05 (44) - - - 
Transcription Regulator MYC +2.85 (20) +2.69 (22) - - - 
Transcription Regulator HTT -2.00 (17) -2.00 (21) - - - 
Transcription Regulator NFKBIA -2.47 (13) -3.21 (16) - -2.81 (8) - 
CYTOKINE IL10 -2.36 (12) -2.65 (16) +2.59 (14) - - 
Transcription Regulator CEBPA - - +2.57 (12) - - 
CYTOKINE IFNG - - +4.14 (48) - - 
CYTOKINE IL1B - - +3.28 (32) - - 
Transcription Regulator NOTCH1 - - +2.17 (6) - - 
Transcription Regulator SFPI1 - - +3.09 (12) - - 
CYTOKINE TNF - - +3.26 (52) - - 
Transcription Regulator STAT3 - - +2.06 (16) - - 
Transcription Regulator STAT6 - - -2.21 (14) - - 
Transcription Regulator GATA4 - - - +2.78 (4) - 
Transcription Regulator MEF2C - - - +2.76 (4) - 
Transcription Regulator TBX5 - - - +2.80 (4) - 
Transcription Regulator ARNTL - - -2.51 (4) - -2.15 (5) 
CYTOKINE IL6 - - - - -2.19 (13) 
 
Similar upstream regulators were present and predicted to be inhibited on day 1 
and day 3 such as NFκBIA, IL10, and HTT, whereas MYC was predicted to be activated 
on both days. On day 3 tumor suppressor p53 was identified as being inhibited and 
asserted transcriptional suppression of many genes. The first few days following iron-
irradiation there is a general suppression of gene expression within cardiomyocytes. In 
contrast on day 7 there was a prominent up regulation of gene expression directed by a 
robust number of upstream regulators (CEBPA, IFN-, IL-1, IL-10, NOTCH1, SPl1, 
STAT3, and TNF-), concurrent with less prominent influences of expression inhibition 
exerted primarily by STAT6 and ARNTL (Figure 8C). The significant activation of 
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several transcription factors (TBX5, GATA-4, and MEF2C) critical in cardiac disease 
modeling and physiological maintenance was observed on day 14 (Figure 8E)36-39. On 
day 28 following iron-irradiation, there was still evidence of significant inhibition of gene 
expression by upstream regulators ARNTL and IL-6 (Figure 8E). 
To identify time-independent changes in biological pathways, genes identified as 
being significantly altered were analyzed in DAVID to identify global KEGG pathways 
in IPA and NIH DAVID. The top 5 KEGG pathways that were identified were 
Parkinson’s disease, Alzheimer’s disease, oxidative phosphorylation, cardiac muscle 
contraction and Huntington’s disease, closely followed by hypertrophic cardiomyopathy 
and dilated cardiomyopathy (Table 3). These top 5 KEGG pathways shared a majority of 
transcripts involved in mitochondrial and oxidative phosphorylation functions (specified 
in italic font, Table 3) illustrating a strong inter-relationship between the same oxidative 
phosphorylation genes that play a role in neurodegenerative and cardiovascular 
disorders/diseases.  
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Table 3: Major Biological and Disease-Related Pathways Associated with Iron-Irradiation Exposure. 
Genes listed in the identified KEGG Pathways were among the top 200 most differentially expressed genes. 
Genes with over-representation FDR<0.05 are listed in italics; associated p-values and FDRs are also listed.   
KEGG Pathway GENES GENES 
 
P-VALUE FDR (%) 
Parkinson's 
Disease 
28 NDUFB7, ATP5B, COX7B, UBE2G2, 
CYC1, COX7C, NDUFS6, CASP9, 
NDUFS1, ATP5J, ATP6, ND1, COX7A1, 
ND2, ND3, NDUFA1, PARK7, COX6C, 
VDAC1, SDHA, ND4L, COX3, UQCRH, 
COX2, COX1, NDUFV2, COX6A2, 
ATP5C1 
4.576E-13 5.420E-10 
Alzheimer's 
Disease 
28 NDUFB7, ATP5B, COX7B, CYC1, 
COX7C, NDUFS6, CASP9, PPP3CB, 
GAPDH, NDUFS1, ATP5J, ATP6, LPL, 
COX7A1, NDUFA1, NAE1, COX6C, 
SDHA, ATP2A2, PSEN1, COX3, UQCRH, 
COX2, COX1, NDUFV2, ATP2A1, 
COX6A2, ATP5C1 
1.486E-10 1.760E-07 
Oxidative 
Phosphorylation 
25 NDUFB7, ATP5B, COX7B, CYC1, 
COX7C, ATP6V0B, NDUFS6, NDUFS1, 
ATP5J, ATP6, ND1, COX7A1, ND2, ND3, 
NDUFA1, COX6C, SDHA, ND4L, COX3, 
UQCRH, COX2, COX1, NDUFV2, 
ATP5C1, COX6A2 
2.214E-10 2.622E-07 
Cardiac Muscle 
Contraction 
18 ACTC1, CACNA2D1, COX7A1, MYL2, 
MYL3, COX7B, CYC1, COX7C, MYH6, 
CACNB4, COX6C, COX3, ATP2A2, 
COX2, UQCRH, COX1, COX6A2, ATP6 
1.600E-08 1.895E-05 
Huntington's 
Disease 
24 POLR2E, COX7A1, NDUFB7, ATP5B, 
COX7B, CYC1, COX7C, NDUFA1, 
DCTN1, COX6C, VDAC1, SDHA, 
NDUFS6, COX3, CASP9, COX2, 
UQCRH, COX1, NDUFV2, COX6A2, 
ATP5C1, NDUFS1, ATP6, ATP5J 
5.967E-07 7.067E-04 
Hypertrophic 
Cardiomyopathy 
(HCM) 
9 ACTC1, CACNA2D1, ATP2A2, MYL2, 
MYL3, ITGB5, MYH6, CACNB4, 
PRKAA2 
0.013 14.438 
Dilated 
Cardiomyopathy
(DCM) 
9 ACTC1, CACNA2D1, ATP2A2, MYL2, 
MYL3, PLN, ITGB5, MYH6, CACNB4 
0.020 21.585 
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Western Blot Analysis of p38 MAPK and NFATc4 Signaling 
Western blot analysis was performed to quantify alterations in p38 MAPK and 
NFATc4 signaling pathways induced by iron-irradiation. Both of these signaling 
pathways have been identified in playing critical regulatory roles in cardiomyocytes40-42. 
In response to ionizing radiation, p38 MAPK has been shown to play a role in 
determining whether a cell will arrest and undergo DNA repair or undergo apoptosis43,44. 
Activation of p38 MAPK requires phosphorylation on residues Thr180 and 
Tyr182. Using phosphorylated specific p38-antibodies immunoblotting was performed to 
analyze the proportion of phosphorylated p38 MAPK to total p38 MAPK. In response to 
iron-irradiation, there was a significant decrease in the phosphorylated state of p38 
MAPK on days 7 and 14. These results infer that 56Fe-IR leads to marked activation of 
p38 MAPK signaling and this may be observed for at least two weeks following 
exposure. However, measurements during the fourth week indicate smaller activation of 
p38 MAPK compared to control (Figure 9A). 
 Immunoblotting was also performed to analyze for NFATc4 activation in 
response to iron particle-IR compared to sham-irradiated mice. Under basal conditions 
NFATc4 remains primarily phosphorylated and inactivated; whereby, dephosphorylation 
results in nuclear translocation where it is able to assert transcriptional activation42. In a 
tissue dependent manner, activated NFATc4 regulates multiple biological processes 
including, cytokine expression (IL-2, IL-4, IL-5, and TNF-α), adipocyte differentiation, 
and cardiac hypertrophy40,42.  
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FIGURE 9: Western Blotting Validates Differential Regulation and Signaling in Response to Iron-
Irradiation. Small samples from the left ventricle were analyzed with western blot analysis. (A) 
Representative western blot scans of heart tissue homogenates from controls and iron-IR mice. Bands 
represent phosphorylated (p) and total (T) p38. GAPDH was used as a loading control. Graphic 
representations of total and phosphorylated p38 protein levels were created using densitometric analysis 
after adjustment with corresponding GAPDH band intensities. (B) Representative western blot scans of 
heart tissue homogenates from controls and iron-IR mice. Bands represent phosphorylated (p) and total (T) 
NFATc4. Actinin was used as a loading control. Graphic representations of total and phosphorylated 
NFATc4 protein levels were created using densitometric analysis after adjustment with corresponding 
Actinin band intensities. Results in graphs represent mean ± SEM. Statistical significance was assigned 
when p < 0.05. 
 
NFATc4 activation was quantified using western blot analysis to examine the 
differential activation in response to iron particles compared to sham-irradiated mice. 
Under basal conditions NFATc4 remains predominantly phosphorylated and 
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inactivated42. Using phosphorylated specific NFATc4-antibodies, immunoblotting was 
performed to determine the ratio of phosphorylated NFATc4 to total NFATc4. This was 
used to estimate amount of NFATc4 in the unphosphorylated activated state. Analysis 
revealed significant and sustained dephosphorylation and subsequent activation of 
NFATc4 following iron-irradiation compared to the controls (Figure 9B). Continued 
activation of NFATc4 signaling was observed throughout the first four weeks, although 
there was a slight decrease in the degree of its activation by week four (less than 2-fold 
difference at week 4 versus 3.5 and 2.5 at weeks 1 and 2, respectively). 
 
Validation of Upstream Regulation with Electrophoretic Mobility Shift Assay 
Analysis of the gene networks created from genes identified as being 
differentially expressed in response to iron-irradiation, revealed specific points of 
upstream regulation. Electrophoretic Mobility Shift Assay (EMSA) was performed to 
validate the presence of selected transcription factors that were expected to be modulated 
in response to iron-irradiation. Three transcription factors (STAT-3, GATA-4, and NF-
κB) identified by microarray analysis (Table 2) were selected for validation using EMSA 
(Figure 10A-D). Nuclear extracts from heart tissues were sampled at days 7, 14, and 28 
following iron-irradiation, in addition to those from sham-irradiated controls. 
The binding activities of both NF-κB and STAT-3 DNA were observed to follow 
similar trends over the first 28 days following iron-irradiation (Figure 10A, B, and D). 
Neither NF-κB nor STAT-3 was measured to have significantly different DNA binding 
activity at day 7. Measurements at day 14 revealed that the DNA binding activities of 
 38 
 
both NF-κB and STAT-3 were significantly decreased compared to the control, 
signifying decreased influence of gene expression by both transcription factors. At day 28 
the DNA binding activity of both NF-κB and STAT-3 increased from day 14. While 
STAT-3 was still significantly decreased, NF-κB had reached a level of activity that was 
not significantly different compared to sham-irradiated mice (Figure 10A, B, and D). 
The transcription factor GATA-4, followed an inverse pattern of upregulation 
compared to NF-κB and STAT-3. GATA-4 had consistent upregulation at days 7, 14, and 
28 compared to sham irradiated controls. This increase in GATA-4 transcriptional 
activity was significantly different compared to the controls for all three days measured 
and its activity peaked on day 14 following iron-irradiation (Figure 10A and C). 
To confirm that the DNA binding activity was due to specific binding of STAT-3, 
GATA-4, and NF-kB to their specific sequence of oligonucleotides, a competitive 
binding assay was performed. Nuclear extracts obtained from heart tissue samples were 
pre-incubated in the presence (or absence) of cold, unlabeled, homologous 
oligonucleotides. These unlabeled oligonucleotides served as competitors to their 
respective transcription factor radio-labeled oligonucleotide probe. As expected the DNA 
binding activity was competitively reduced by the addition of homologous unlabeled 
oligonucleotides (Figure 10A, right panel). Competitive inhibition of the DNA binding 
activity with unlabeled consensus sequences confirmed the specific binding of STAT-3, 
GATA-4, and NF-κB. These EMSA results assisted in the validation that these upstream 
regulators acted to cause the differential changes in downstream expression following 
iron-irradiation.  
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FIGURE 10: Activation of Transcription Factors STAT-3, GATA-4, and NF-kB Following 56Fe-
Irradiation. (A, Left Panel) Autoradiogram showed a time-dependent activation of STAT-3 and GATA-4, 
and inhibition of NF-kB DNA-binding activity following 56Fe-IR. (A, Right Panel) Significant decrease in 
STAT-3, GATA-4, and NF-kB binding activity in the presence of respective competitor confirms the 
specificity binding to their respective sequence. (B, C, D) Graphic representation of the percent change in 
STAT-3, GATA-4, and NF-kB DNA binding activity on days 7, 14, and 28, compared to control samples. 
Data represent mean ± SEM. Statistical significance was assigned when p < 0.05. 
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DISCUSSION 
 
Cardiomyocytes (CMs) appear to respond distinctly to different types of HZE 
particle-IR and may inflict long-lasting effects. Identification of physiological changes 
and their associated molecular mechanisms is paramount to estimating degenerative CV 
risks associated with space-IR. One of the possible mechanisms that can explain and 
potentiate changes to cardiovascular homeostasis is that HZE particle-irradiation can 
elicit alterations of CM gene expression.  
Evidence exists that the biological effects and molecular mechanisms elicited 
after low dose IR may be different from responses in exposure to a high dose of the same 
type of radiation45-47. Similarly, it is well recognized that the relative biological 
effectiveness (estimated measuring of specific biological outcomes such as cell killing, 
mutagenesis, and carcinogenesis) can vary greatly depending on the type of radiation a 
biological sample has been exposed to. What remains unclear is if the differences are the 
result of unique molecular mechanisms to different types of particle radiation. Thus one 
of the objectives of our studies was to help address this question using cardiomyocytes as 
a model system.  
 
Microarray Analysis  
This study revealed evidence that even low dose 56Fe-IR (15 cGy, 1 GeV/n) can 
elicit a robust response in cardiomyocytes observed with the alteration in the expression 
of 400 genes and these alterations can remain substantial for at least 28 days following 
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exposure. In contrast, significantly robust alterations of CM gene expression were not 
identified after low dose 1H-IR (90 cGy at 1 GeV), using the same filtering and statistical 
criteria. Even after raising the false discovery rate to >33 % (for the proton-IR dataset) 
only 21 genes were identified among all the time points. Comparing these 21 genes to the 
400 identified as differentially expressed after iron-IR, there were only four genes 
observed in both datasets (Car14, Dbp, Lcn2, and Trim7). Together, these data suggests 
that the biological effects observed after 56Fe-IR (15 cGy, 1 GeV/n) and 1H-IR (90 cGy at 
1 GeV) act through different mechanisms, where the response to 56Fe-IR (15 cGy, 1 
GeV/n) may at least partially be described through alterations of gene expression.  
 
IPA Analysis and Functional Activity Networks  
Further analysis of the genes identified as being differentially expressed revealed 
relationships of immense complexity between gene transcription and the regulation of 
multiple biological pathways, which included, but were not limited to; inflammation, cell 
trafficking, DNA damage and repair, free radical scavenging, cell survival, and apoptosis 
(Table 1). From these data, one interesting observation is that genes regulating cell 
apoptosis were not immediately increased after irradiation, but rather the first response 
(day 1) is a significant upregulation of the genes associated with cellular growth and 
proliferation. It would seem like a logical assumption to predict after IR—and the 
subsequent direct damage to DNA—that the first response of a cell would be an opposite 
response by inducing expression of the genes governing apoptosis. However, we did not 
observe an increased expression of these genes associated with apoptosis until 7 days 
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post-IR. Another equally interesting observation is that free radical scavenging is also 
down regulated on day 1, when one would hypothesize that the amount of free-radicals 
would already be significantly increased and that a down regulation of these associated 
genes would be deleterious for cell survival. Oxidative DNA damage, assessed by 8-Oxo-
de-oxy-Guanosine and p-H2AX foci content, has previously been observed to remain 
elevated for at least 8 weeks following 56Fe-IR of a similar dose25,48. Standing in 
agreement to this study, long-term activation of genes associated with free radical 
scavenging was observed into the fourth week and predicts long lasting oxidative 
damage. One final observation is that there are relatively few (2) functional categories 
identified as being statistically significant on day 1, while the most functional categories 
identified (7) occurred on days 7 and 28.  
Processing the differential gene lists from 56Fe-IR microarray data to create 
functional activity networks of the major functional categories identified (cell death and 
survival, free radical scavenging, and inflammation) a commonality between all three can 
easily be appreciated, visually (Figures 5-7).  Namely, gene expression alterations follow 
a general pattern of marked down-regulation, initially (days 1 and 3 post-IR); followed by 
a period of upregulation (day 7); and a more mixed response of gene expression towards 
the latter time points analyzed (days 14 and 28). This data suggests a sequential and 
prolonged response in gene expression of cardiomyocytes following 56Fe-IR.  
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Expression Results Compared to Previous Studies 
Previous studies have analyzed differences in gene expression profiles among 
different qualities of HZE particle-IR and dose, however over a more limited 
timeframe47,49-51. Among the major findings was that radiation quality (i.e. composition) 
was the leading source of variation, followed by the time point analyzed post-IR, in 
explaining differences among genes identified as differentially expressed49,50. Although 
these studies have focused on other model systems such as the human bronchial epithelial 
(HBE) cells or in the rat hippocampus, the findings of this study are consistent in the fact 
that given a specific tissue, differences in particle quality may precipitate differences in 
biological effects through distinct molecular responses. This study also identified 
distinctly different genes as being differentially expressed compared to similarly designed 
studies using different cell lines, but the same quality of radiation49,50. We hypothesize 
multiple reasons for these differences in our iron exposure data, which include the cell 
type (cardiomyocytes), dose (15 cGy) and time point(s) analyzed following radiation 
exposure. Although this study showed little gene concordance compared to the Ding et 
al., 2013 study, there were key similarities existing in the functional categories identified 
through IPA between the two studies50. Similar functional categories identified as being 
modulated by both studies included cellular growth and proliferation, cytokine 
production, apoptosis, and cell-cycle interactions. Taken together suggests that the factors 
governing modulations of gene expression following IR must at least be dependent on 
particle quality, radiation dose, timing of assessment, and tissue or biological system 
studied. The fact that the specific genes differ between these studies may not be as 
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important as the fact that they share similar biological pathway modulations, which may 
in turn drive cell fate. 
 
KEEG Pathway Analysis  
The top five KEGG pathways identified (Parkinson’s disease, Alzheimer’s 
disease, oxidative phosphorylation, cardiac muscle contraction, and Huntington’s 
disease) shared many common transcripts involved in mitochondrial and oxidative 
phosphorylation functions thus illustrating a strong inter-relationship between oxidative 
phosphorylation genes that play roles in both neurodegenerative and cardiovascular 
disorders/diseases (Table 3). The five pathways were closely followed by hypertrophic 
and dilated cardiomyopathy disease pathways (Table 3). The modulation of these genes 
in response to 56Fe-IR may be directly linked to molecular mechanisms that describe the 
alterations in functional cardiac physiology that have been previously observed25. Major 
biological pathway analysis illustrates that multiple disease-related pathways, such as 
cardiomyopathies and neurological disorders are affected by iron IR, and these common 
pathways are linked by molecular mechanisms associated with mitochondrial function as 
well as oxidative phosphorylation (Table 3). The significant overlap between 
neurodegenerative disease pathways and cardiac muscle pathways was an unexpected 
finding given our focus on cardiomyocytes. These findings may substantiate a common 
link in the underlying molecular mechanisms for radiation-induced neurodegenerative 
and cardio-degenerative disease processes.  
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Significance of Upstream Regulation  
Our gene profile studies were predictive for modulation of specific points of 
upstream transcription regulation. Electrophoretic mobility shift assays were conducted to 
test and validate the predictions made from the microarray findings. Several significant 
transcription factors (STAT-3, GATA-4, and NF-B) predicted to cause downstream 
alterations in expression were validated through EMSA. The EMSA findings validated 
the predictions that there would be increased transcriptional activity mediated through 
GATA-4, while decreased transcriptional activity mediated STAT-3 and NF-B 
following 56Fe-IR. It was predicted that the transcriptional factors TBX5, GATA-4, and 
MEF2C were to be activated on day 14 following 56Fe-IR. Activation of these 
transcription factors have been shown to have significant roles in regulating 
cardiomyocytes, cardiac morphogenesis, myogenesis, vascular development, and 
protection from pressure overload-induced heart failure36-39.  
 
Significant Alterations in Cellular Signaling  
Ionizing radiation has been shown to elicit p38 MAPK activation43. Activated p38 
positively regulates cell death, while decreased levels of activated p38 is associated with 
cell-cycle arrest. Within cardiomyocytes, p38 MAPK has also been shown to play key 
roles in cardiomyocyte hypertrophy, transitions from compensated to decompensated 
heart failure, as well as ischemic myocardial infarction and subsequent reperfusion 
injury41,52-56. Furthermore inhibition of the p38 MAPK signaling pathway has shown to 
be beneficial in limiting ischemic reperfusion injury and preserving cardiac function44,54.  
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 Following 56Fe-IR, activation p38 MAPK was observed as an early response 
(days 7 and 14 post-IR), while activation p38 MAPK was reduced later on (day 28). 
Early increased p38 MAPK activity may indicate the activation of compensatory and 
protective mechanisms; whereas the subsequent reduction of p38 MAPK activation may 
be an early indication of cardiac de-compensation in development. Furthermore decreases 
in p38 MAPK signaling following 56Fe-IR hearts could potentially negate signaling 
processes that are beneficial/cardio-protective. 
DNA damage inflicted by radiation exposure has been shown to activate both p38 
MAPK and p53 signaling43,57. Activation of p38 MAPK also has been shown to modulate 
p5357. At low doses of IR they have been observed to play separate roles to induce cell-
cycle arrest to allow for DNA repair, while at higher doses they work together to induce 
apoptosis57-59. The early onset of p38 MAPK activation together with the observed down 
regulation of p53 signaling on day 3 reveal a multifactorial and complex response to 56Fe-
IR. These observations may help explain why the initial response to IR was an 
upregulation of proliferation genes met by a later response of increased apoptosis activity 
on day 7.   
Activated p38 MAPK has also been shown to increase NFATc4 phosphorylation 
(deactivates NFATc4), translocation from the nucleus, and subsequent decreased 
expression of NFATc4 signaling targets42,60. One of the major mechanisms of cardiac 
compensation is through hypertrophy. The transcription factor, NFATc4, is a significant 
mediator of cardiac hypertrophy40,61. The observed activation of NFATc4 signaling 
during the first four weeks following 56Fe-IR may represent the onset and activation of 
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cardiac hypertrophy signaling. By the fourth week, NFATc4 activation levels were 
observed to be returning towards their basal levels (less than 2-fold difference at week 4, 
versus 3.5 and 2.5 at weeks 1 and 2; respectively) possibly indicating late regulation by 
p38. However, NFATc4 activation was increased early on in the presence of activated 
p38 MAPK, which suggests the presence of additional mechanisms responsible for the 
net NFATc4 activation that is observed. 
Further work will be needed to determine whether these changes are shared across 
different cell types and other organ systems. Additional studies will also be needed to 
determine the molecular alterations of other HZE particles and to identify any 
commonalities shared among different HZE particle types. This work provides new 
insights detailing the biological effects and molecular alterations following HZE particle 
radiation, which may be important for cardiovascular risk estimates for astronauts’ 
exposure during interplanetary missions and for patients receiving particle type radiation 
therapy. As additional data becomes available it may be possible to identify specific 
molecular alterations that correlate with a specific physiologic response or disease 
process. Identification of such biomarkers could be useful during interplanetary missions 
to identify the early stages of a disease process in astronauts and help ensure proper 
preventive precautions are taken. Similar benefits also apply to patients receiving HZE 
particle radiation. 
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CONCLUSION 
 
The major findings of this study were: (i) low dose 56Fe-IR (15 cGy, 1 GeV/n) 
elicits significant changes in cardiomyocyte gene expression; (ii) using the same filtering 
criteria low dose 1H-IR (90 cGy at 1 GeV) failed to elicit statistically significant changes 
in cardiomyocyte gene expression; (iii) long term biological effects of low dose 56Fe-IR 
were identified as significant at the last time point analyzed (28 days post-IR); (iv) 
following low dose 56Fe-IR major cellular processes that exhibited significant modulation 
included: inflammatory response, cell death and survival, free radical scavenging, 
cardiovascular disease development, and cellular development processes; (v) 
differentially expressed genes identified common upstream  regulatory kinases, such as 
p38 MAPK, and transcription factors (STAT-3, GATA-4, NF-κB, NFATc4); (vi) 
signaling pathways identified have significant roles in the maintenance of cardiovascular 
homeostasis and are critical for the proper response to tissue damaging stimuli, i.e., 
ionizing radiation; (vii) two weeks following 56Fe-IR the activation of several cardiac-
specific developmental transcription factors, such as TBX5, GATA-4, and MEF2C, 
strongly suggest the activation of cardio-protective and regeneration mechanisms; (viii) 
significant transcript overlap between neuro and cardio-degenerative disease pathways 
was observed, which may support a common link in underlying molecular mechanisms 
for IR-associated degenerative processes; (ix) the overlap among  neuro and cardio-
degenerative disease pathways suggests that the development of effective radiation 
mitigation strategies for the prevention and treatment of cardio-degenerative diseases 
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may be effective for  neuro-degenerative diseases, as well. 
This study highlights very distinct changes in gene expression between low dose 
56Fe-IR (15 cGy, 1 GeV/n) and 1H-IR (90 cGy at 1 GeV). Because low dose 1H-IR did 
not elicit significant alterations in gene expression, the mechanisms of the physiological 
changes that have been previously reported are still undetermined. Further determination 
of the exact molecular mechanisms and their associated effects on cardiovascular 
physiology will help identify which biological HZE-IR responses are deleterious under 
which conditions. Using this data we can begin to accurately assess excess risk placed 
onto astronauts from deep space radiation. Through these findings scientists may identify 
new novel biomarkers that may be used to augment current CV disease biomarkers in 
both the clinic and in the specific application for future deep space travel.  
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